Comparison of Laparoscopic to Vaginal Surgical Repair for Uterine Prolapse
Primary Purpose
Uterine Prolapse
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Laparoscopic supracervical hysterectomy with sacropexy
Vaginal hysterectomy with uterosacral colposuspension
Sponsored by
About this trial
This is an interventional treatment trial for Uterine Prolapse focused on measuring Uterine Prolapse, Laparoscopy, Hysterectomy, vaginal
Eligibility Criteria
Inclusion Criteria:
- Patients with primary symptomatic uterine prolapse
- ≥ 18 years of age
- Considering pelvic reconstructive surgery
Exclusion Criteria:
- Unwillingness to be randomized to one of two surgical approaches
- Pregnant or planning to maintain their future fertility
- Unable to have general anesthesia
- Currently undergoing chemotherapy OR has current or history of pelvic radiation
- Previous adverse reaction to synthetic mesh
- Recent history of abnormal paps (past 10 years)
- Cervical or uterine cancers
- Previous hysterectomy
- Previous central vault or uterine prolapse repair
- Uterus ≥ 14 weeks size
- Uterine cancer
- History of significant pelvic adhesive disease
- Elongated cervix (length D to C > 6cm)
- Fibroid ≥ 7cm
- Post menopausal with enlarged uterus
Sites / Locations
- Brigham And Women's Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Laparoscopic Repair
Vaginal Repair
Arm Description
Laparoscopic supracervical hysterectomy with sacropexy
Vaginal hysterectomy with uterosacral colposuspension
Outcomes
Primary Outcome Measures
Whether or not POPQ points AA, BA, Ap, or Bp are at less than 0 cm from the hymen OR whether point C descends less than 1/3 of the total vaginal length (TVL)
Absence of re-treatment for prolapse at 2 years
A negative response to "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?"
This is a question from the standardized questionnaire called Pelvic Floor Discomfort Inventory (PFDI).
Secondary Outcome Measures
Changes in POPQ measurements
Changes in Patient-reported quality of life scores from the EQ-5D, PFDI, PFIQ, SF-12, Standard Gamble Interview, Pain Scale and Activity Assessment
EQ-5D assesses a patient's health that day PFDI- pelvic floor discomfort questions PFIQ - pelvic floor impact on daily activity questions SF-12 - general health/quality of life questions Standard Gamble Interview - an overall general health/quality of life questionnaire
Change in patient reported sexual questionnaire, PISQ
PISQ - pelvic organ prolapse/urinary incontinence sexual questionnaire
Frequencies of surgical and post-operative complications
Complications will be classified and reported, based on severity.
Full Information
NCT ID
NCT01594372
First Posted
May 4, 2012
Last Updated
March 2, 2022
Sponsor
Brigham and Women's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01594372
Brief Title
Comparison of Laparoscopic to Vaginal Surgical Repair for Uterine Prolapse
Official Title
Randomized Trial Comparing Vaginal Hysterectomy to Laparoscopic Supracervical Hysterectomy With Vault Suspension for Symptomatic Uterine Prolapse
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Terminated
Why Stopped
Laproscopic procedure not offered at this time; will not be offered for the foreseeable, thus we are unable to randomize participants between the two arms.
Study Start Date
January 2013 (undefined)
Primary Completion Date
May 2015 (Actual)
Study Completion Date
May 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Investigators intend to conduct a prospective randomized trial to compare vaginal hysterectomy with uterosacral colposuspension to laparoscopic supracervical hysterectomy with sacrocervicopexy. Both surgeries are minimally-invasive surgical standards of care for uterine prolapse repair. Nobody knows if one procedure is superior to the other, as they have not been compared directly. The investigators hypothesize that there is no difference in objective, subjective, or cost-effectiveness between the two procedures for up to two years after surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uterine Prolapse
Keywords
Uterine Prolapse, Laparoscopy, Hysterectomy, vaginal
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Laparoscopic Repair
Arm Type
Active Comparator
Arm Description
Laparoscopic supracervical hysterectomy with sacropexy
Arm Title
Vaginal Repair
Arm Type
Active Comparator
Arm Description
Vaginal hysterectomy with uterosacral colposuspension
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic supracervical hysterectomy with sacropexy
Intervention Description
Will involve laparoscopic entry to the abdomen to remove the uterus and suspension of the cervix and vaginal cuff to the sacrum with mesh. We will allow surgeons to conduct the surgery as they have perfected it
Intervention Type
Procedure
Intervention Name(s)
Vaginal hysterectomy with uterosacral colposuspension
Intervention Description
Will involve removing the uterus vaginally followed by suspending the vaginal cuff to the high (proximal) uterosacral ligaments bilaterally restoring the vagina to its normal axis.
Primary Outcome Measure Information:
Title
Whether or not POPQ points AA, BA, Ap, or Bp are at less than 0 cm from the hymen OR whether point C descends less than 1/3 of the total vaginal length (TVL)
Time Frame
24 months
Title
Absence of re-treatment for prolapse at 2 years
Time Frame
24 months
Title
A negative response to "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?"
Description
This is a question from the standardized questionnaire called Pelvic Floor Discomfort Inventory (PFDI).
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Changes in POPQ measurements
Time Frame
baseline, 6 week, and 3, 12, and 24 months
Title
Changes in Patient-reported quality of life scores from the EQ-5D, PFDI, PFIQ, SF-12, Standard Gamble Interview, Pain Scale and Activity Assessment
Description
EQ-5D assesses a patient's health that day PFDI- pelvic floor discomfort questions PFIQ - pelvic floor impact on daily activity questions SF-12 - general health/quality of life questions Standard Gamble Interview - an overall general health/quality of life questionnaire
Time Frame
baseline, 3, 12, and 24 months
Title
Change in patient reported sexual questionnaire, PISQ
Description
PISQ - pelvic organ prolapse/urinary incontinence sexual questionnaire
Time Frame
baseline, 3, 12 and 24 months
Title
Frequencies of surgical and post-operative complications
Description
Complications will be classified and reported, based on severity.
Time Frame
up to 2 years post-operatively
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with primary symptomatic uterine prolapse
≥ 18 years of age
Considering pelvic reconstructive surgery
Exclusion Criteria:
Unwillingness to be randomized to one of two surgical approaches
Pregnant or planning to maintain their future fertility
Unable to have general anesthesia
Currently undergoing chemotherapy OR has current or history of pelvic radiation
Previous adverse reaction to synthetic mesh
Recent history of abnormal paps (past 10 years)
Cervical or uterine cancers
Previous hysterectomy
Previous central vault or uterine prolapse repair
Uterus ≥ 14 weeks size
Uterine cancer
History of significant pelvic adhesive disease
Elongated cervix (length D to C > 6cm)
Fibroid ≥ 7cm
Post menopausal with enlarged uterus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vatche A Minassian, MD, MPH
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham And Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparison of Laparoscopic to Vaginal Surgical Repair for Uterine Prolapse
We'll reach out to this number within 24 hrs